Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study

ObjectiveThe objective of this study was to study provider attitudes of and perceived barriers to the clinical use of pharmacogenomics before and during participation in an implementation program.Participants and methodsFrom 2012 to 2017, providers were recruited. After completing semistructured int